Table 2.
Donor | HLA class I A and B type | Timepoint | Deduced amino acid sequence | % Provial DNA clones | ||||||
---|---|---|---|---|---|---|---|---|---|---|
SLYNTVATL Responders | ||||||||||
003 | A2/3 B7/51 | 07/87 | GSEELRSLYNTVATLYCVHQR | 100% | n = 8 | |||||
06/95 | GSEELRSLYNTVATLYCVHQR | 82% | n = 13 | |||||||
GSEERK SLYNTVATLYCVHQR | 6% | n = 1 | ||||||||
GSEELRSLLNTVATLYCVHQR | 6% | n = 1 | ||||||||
GSEELK SLYNTVATLYCVHKR | 6% | n = 1 | ||||||||
12/95 | GSEELRSLYNTVATLYCVHQR | 100% | n = 16 | |||||||
06/96 | GSEELRSLYNTVATLYCVHQR | 100% | n = 5 | |||||||
077 | A2/3 B41/49 | 12/94 | GSEELRSLYNTVATLYCVHQR | 100% | n = 3 | |||||
1M | A2/1 B7/57 | 08/96 | GSEERK SLYNTVATLYCVHQK | 100% | n = 4 | |||||
5M | A2/32 B7/57 | 10/93 | GSEELRSLYNTIAVLYCVHQR | 90% | n = 28 | |||||
GSEELRSLYNTVAVLYCVHQR | 10% | n = 3 | ||||||||
11/95 | GSEEVRSLYNTVATLYCVHQR | 100% | n = 4 | |||||||
868 | A2/24 B27/35 | 10/95 | GSEELRSLYNTVATLYCVHQR | 73% | n = 8 | |||||
GSEELRSLYNTIATLYCVHQR | 9% | n = 1 | ||||||||
GSEELK SLYNTIATLYCVHQR | 9% | n = 1 | ||||||||
GSEERK SLYNTVATLYCVHQR | 9% | n = 1 | ||||||||
04/96 | GSEELRSLYNTIAVLYCVHQR | 92% | n = 11 | |||||||
GSEELK SLYNTIATLYCVHQR | 8% | n = 1 | ||||||||
08/96 | GSEELK SLYNTVATLYCVHQR | 100% | n = 5 | |||||||
SLYNTVATL Nonresponders | ||||||||||
023 | A2/3 B7/51 | 07/87 | GSEKLK SLHNTVATLYCVHQR | 100% | n = 3 | |||||
06/95 | GSEELQ SLHNAVAVLYCVHQR | 70% | n = 7 | |||||||
GSEELE SLYNTVATLYCVHQR | 10% | n = 1 | ||||||||
GSEELK SLYNTVATLYCVHQR | 10% | n = 1 | ||||||||
GSEELK SLSNTIATLYCVHQR | 10% | n = 1 | ||||||||
12/95 | GSEELQ SLHNAVAVLYCVHQR | 100% | n = 10 | |||||||
07/96 | GSEELQ SLHNAVAVLYCVHQR | 100% | n = 16 | |||||||
008 | A2/68 B8/65 | 04/91 | GSEEFRSLFNTVATLYCVHQR | 50% | n = 3 |
Donor | HLA class I A and B type | Timepoint | Deduced amino acid sequence | % Proviral DNA clones | ||||||
---|---|---|---|---|---|---|---|---|---|---|
GSEEFRSLFNTVATLYCVHQK | 17% | n = 1 | ||||||||
GSEEFRSLLNTVATLYCVHQR | 17% | n = 1 | ||||||||
GSEEFRSLSNTVATLYCVHQR | 17% | n = 1 | ||||||||
04/92 | GSEELK SLFNTVAVLYCVHQR | 38% | n = 8 | |||||||
GSEELRSLFNTVAVLYCVHQR | 19% | n = 4 | ||||||||
GSEELK SLFNTIAVLYCVHQR | 10% | n = 2 | ||||||||
GSEEFRSLFNTVATLYCVHQR | 5% | n = 1 | ||||||||
GSEELK SLFNTVATLYCVHQR | 14% | n = 3 | ||||||||
GSEELRSLYNTIAVLYCVHQR | 14% | n = 3 | ||||||||
065 | A2/1 B8/44 | 02/93 | GSEELK SLYNTVATLYCVHQR | 100% | n = 28 | |||||
08/94 | GSEELK SLYNTVATLYCVHQR | 100% | n = 1 | |||||||
05/96 | GSEELK SLYNTVATLYCVHQR | 100% | n = 2 | |||||||
GSEELRSLYNTVATLYCVHQR | 100% | n = 1 | ||||||||
241 | A2/26 B39/62 | 02/93 | GSEELK SLYNTIATLYCVHQQ | 100% | n = 6 | |||||
606 | A2/- B62/65 | 10/94 | GSEELK SLFNTVATLYCVHKR | 75% | n = 3 | |||||
GSEELK SLFNTVAVLYCVHKR | 25% | n = 1 | ||||||||
SLYNTVATL Responder Switched to Nonresponder | ||||||||||
46M | A2/1 B8/62 | 09/94 | GSEELRSLYNTVATLYCVHQR | 33% | n = 6 | |||||
GSEELK SLYNTVATLYCVHQR | 17% | n = 3 | ||||||||
GSEELRSLFNTVATLYCVHQR | 11% | n = 2 | ||||||||
GSEELK SLFNTVATLYCVHQR | 39% | n = 7 | ||||||||
06/95 | GSEELK SLFNTVATLYCVHQR | 100% | n = 2 | |||||||
04/96 | GTEELR SLFNTVATLYCVHQR | 100% | n = 3 |
Continued
Proviral DNA sequences and the encoded amino acid sequences at the region of the Gag epitope for five Gag responders, five nonresponders, and one donor whose Gag response disappeared between the first timepoint and the last; showing the timepoint (mo/yr), amino acid sequence (SLYNTVATL epitope underlined, with six amino acids either side of the epitope shown; differences from HIVLAI sequence shown in bold); number of clones sequenced, and proportion encoding a particular amino acid sequence.